The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Open accessAbstract
This review summarizes our current understanding of nonalcoholic fatty liver disease (NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a specific genetic background and multiple environmental/metabolic "hits". The role of gut microbiota, lipotoxicity, inflammation and their molecular pathways is reviewed in-depth. We also discuss the epidemiology and natural history of NAFLD by pinpointing the remarkably high prevalence of NAFLD worldwide and its inherent systemic complications: hepatic (steatohepatitis, advanced fibrosis and cirrhosis), cardio-metabolic (cardiovascular disease, cardiomyopathy, arrhythmias and type 2 diabetes) and neoplastic (primary liver cancers and extra-hepatic cancers). Moreover, we critically report on the diagnostic role of non-invasive biomarkers, imaging techniques and liver biopsy, which remains the reference standard for diagnosing the disease, but cannot be proposed to all patients with suspected NAFLD. Finally, the management of NAFLD is also reviewed, by highlighting the lifestyle changes and the pharmacological options, with a focus on the innovative drugs. We conclude that the results of ongoing studies are eagerly expected to lead to introduce into the clinical arena new diagnostic and prognostic biomarkers, prevention and surveillance strategies as well as to new drugs for a tailored approach to the management of NAFLD in the individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
The impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Self-citationBedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
Self-citationByrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationSingh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationBhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., & Smeeth, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60892-8 · Cited by 1,707
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,553
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Self-citationMicrobes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Self-citationBedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Self-citationKozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Endoplasmic reticulum stress in liver disease
Malhi, H., & Kaufman, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.005 · Cited by 1,173
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Self-citationRatziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Self-citationSpeliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Self-citationBarry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L. M., Lundbom, N., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 804
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 770
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13264 · Cited by 717
Self-citationFracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 711
Self-citationNonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Self-citationMancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Self-citationSterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Wong, V. W.-S., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Li, M. K.-P., Chan, H.-Y., Chim, A. M.-L., Yu, J., Sung, J. J.-Y., & Chan, H. L.-Y. (2010) · Gut · doi:10.1136/gut.2009.205088 · Cited by 648
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Self-citationParadis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 564
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
Younossi, Z. M., Stepanova, M., Negro, F., Hallaji, S., Younossi, Y., Lam, B., & Srishord, M. (2012) · Medicine · doi:10.1097/md.0b013e3182779d49 · Cited by 559
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
A high-fat diet is associated with endotoxemia that originates from the gut
Pendyala, S., Walker, J. M., & Holt, P. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.034 · Cited by 546
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., Motta, B. M., Kaminska, D., Rametta, R., Grimaudo, S., et al. (2015) · Hepatology · doi:10.1002/hep.27490 · Cited by 533
Self-citationHallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529
Pais, R., Charlotte, F., Fedchuk, L., Bedossa, P., Lebray, P., Poynard, T., & Ratziu, V. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.027 · Cited by 522
Sanyal, A. J., Banas, C., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Heuman, D., Coterrell, A., Fisher, R. A., et al. (2006) · Hepatology · doi:10.1002/hep.21103 · Cited by 522
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
PPARs: Fatty acid sensors controlling metabolism
Poulsen, L. L. C., Siersbæk, M., & Mandrup, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.003 · Cited by 510
Fedchuk, L., Nascimbeni, F., Pais, R., Charlotte, F., Housset, C., Ratziu, V., & the LIDO Study Group (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12963 · Cited by 500
Self-citationMultiparametric magnetic resonance for the non-invasive diagnosis of liver disease
Banerjee, R., Pavlides, M., Tunnicliffe, E. M., Piechnik, S. K., Sarania, N., Philips, R., Collier, J. D., Booth, J. C., Schneider, J. E., Wang, L. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.002 · Cited by 498
Ratziu, V., Massard, J., Charlotte, F., Messous, D., Imbert-Bismut, F., Bonyhay, L., Tahiri, M., Munteanu, M., Thabut, D., Cadranel, J. F., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-6 · Cited by 492
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 471
Self-citationBhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J. M., Saracco, G., Adams, L. A., Charatcharoenwitthaya, P., Topping, J. H., Bugianesi, E., et al. (2011) · Hepatology · doi:10.1002/hep.24491 · Cited by 450
Self-citationEpidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationBugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
Self-citationLiver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome
Roulot, D., Czernichow, S., Le Clésiau, H., Costes, J.-L., Vergnaud, A.-C., & Beaugrand, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.020 · Cited by 439
Long–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
Hui, J. M., Kench, J. G., Chitturi, S., Sud, A., Farrell, G. C., Byth, K., Hall, P., Khan, M., & George, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50320 · Cited by 437
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Self-citationCharacteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.01.023 · Cited by 420
Leamy, A. K., Egnatchik, R. A., & Young, J. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.004 · Cited by 412
Statin use and non-alcoholic steatohepatitis in at risk individuals
Dongiovanni, P., Petta, S., Mannisto, V., Mancina, R. M., Pipitone, R., Karja, V., Maggioni, M., Kakela, P., Wiklund, O., Mozzi, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.006 · Cited by 390
Self-citationManagement of NAFLD: a stage-based approach
Rinella, M. E., & Sanyal, A. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.3 · Cited by 385
Bernstein, D. L., Hülkova, H., Bialer, M. G., & Desnick, R. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.014 · Cited by 379
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
Yang, J. D., Abdelmalek, M. F., Pang, H., Guy, C. D., Smith, A. D., Diehl, A. M., & Suzuki, A. (2014) · Hepatology · doi:10.1002/hep.26761 · Cited by 374
Singal, A. G., Manjunath, H., Yopp, A. C., Beg, M. S., Marrero, J. A., Gopal, P., & Waljee, A. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.476 · Cited by 362
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
Leung, J. C., Loong, T. C., Wei, J. L., Wong, G. L., Chan, A. W., Choi, P. C., Shu, S. S., Chim, A. M., Chan, H. L., & Wong, V. W. (2017) · Hepatology · doi:10.1002/hep.28697 · Cited by 348
From NAFLD in clinical practice to answers from guidelines
Nascimbeni, F., Pais, R., Bellentani, S., Day, C. P., Ratziu, V., Loria, P., & Lonardo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.044 · Cited by 337
Self-citationIn vivo molecular and genomic imaging: new challenges for imaging physics
Cherry, S. R. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/3/r01 · Cited by 334
Autophagy and Lipid Droplets in the Liver
Martinez-Lopez, N., & Singh, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105336 · Cited by 333
Browning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007674 · Cited by 328
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Koehler, E. M., Plompen, E. P. C., Schouten, J. N. L., Hansen, B. E., Darwish Murad, S., Taimr, P., Leebeek, F. W. G., Hofman, A., Stricker, B. H., Castera, L., et al. (2016) · Hepatology · doi:10.1002/hep.27981 · Cited by 321
A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitis
Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D. V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A. T., Bartneck, M., Neumann, U. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403856 · Cited by 314
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Polyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 311
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Guo, J., & Friedman, S. L. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-21 · Cited by 311
Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307
VanWagner, L. B., Wilcox, J. E., Colangelo, L. A., Lloyd‐Jones, D. M., Carr, J. J., Lima, J. A., Lewis, C. E., Rinella, M. E., & Shah, S. J. (2015) · Hepatology · doi:10.1002/hep.27869 · Cited by 305
Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis
Roh, Y. S., & Seki, E. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12019 · Cited by 301
Changing trends in malignant transformation of hepatocellular adenoma
Farges, O., Ferreira, N., Dokmak, S., Belghiti, J., Bedossa, P., & Paradis, V. (2011) · Gut · doi:10.1136/gut.2010.222109 · Cited by 299
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.021 · Cited by 294
Self-citationBarreyro, F. J., Holod, S., Finocchietto, P. V., Camino, A. M., Aquino, J. B., Avagnina, A., Carreras, M. C., Poderoso, J. J., & Gores, G. J. (2015) · Liver International · doi:10.1111/liv.12570 · Cited by 294
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
Marchesini, G., Petta, S., & Dalle Grave, R. (2016) · Hepatology · doi:10.1002/hep.28392 · Cited by 292
Self-citationBile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Porez, G., Prawitt, J., Gross, B., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 286
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology · doi:10.1002/hep.26695 · Cited by 279
Self-citationZelber-Sagi, S., Lotan, R., Shlomai, A., Webb, M., Harrari, G., Buch, A., Nitzan Kaluski, D., Halpern, Z., & Oren, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.011 · Cited by 277
Safadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., Safadi, R., Konikoff, F. M., Hershkovitz, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.038 · Cited by 274
Nonalcoholic fatty liver disease and aging: epidemiology to management.
Bertolotti, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14185 · Cited by 270
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Wong, V. W.-S., Wong, G. L.-H., Tsang, S. W.-C., Fan, T., Chu, W. C.-W., Woo, J., Chan, A. W.-H., Choi, P. C.-L., Chim, A. M.-L., Lau, J. Y.-W., et al. (2011) · Gut · doi:10.1136/gut.2011.237974 · Cited by 256
Lin, S. C., Heba, E., Wolfson, T., Ang, B., Gamst, A., Han, A., Erdman, J. W., O’Brien, W. D., Andre, M. P., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.027 · Cited by 254
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
Bravi, F., Bosetti, C., Tavani, A., Gallus, S., & La Vecchia, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.039 · Cited by 253
PNPLA3 I148M polymorphism and progressive liver disease
Dongiovanni, P. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.6969 · Cited by 252
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S., Pirola, C. J., & Targher, G. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236
Self-citationReddy, S. K., Steel, J. L., Chen, H.-W., DeMateo, D. J., Cardinal, J., Behari, J., Humar, A., Marsh, W. J., Geller, D. A., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25536 · Cited by 224
Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 217
Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Sauvinet, V., Noël, B., Flet, L., Vidal, H., Staels, B., & Laville, M. (2013) · Diabetes Care · doi:10.2337/dc12-2012 · Cited by 215
Pavlides, M., Banerjee, R., Sellwood, J., Kelly, C. J., Robson, M. D., Booth, J. C., Collier, J., Neubauer, S., & Barnes, E. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.009 · Cited by 212
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Self-citationBruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A., Monasterolo, F., Casadei-Giunchi, D., et al. (2005) · BMJ · doi:10.1136/bmj.38391.663287.e0 · Cited by 201
Gan, L. T., Van Rooyen, D. M., Koina, M. E., McCuskey, R. S., Teoh, N. C., & Farrell, G. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.024 · Cited by 198
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., & Byrne, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057183 · Cited by 197
Self-citationFriedman, S., Sanyal, A., Goodman, Z., Lefebvre, E., Gottwald, M., Fischer, L., & Ratziu, V. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.02.012 · Cited by 197
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
Miele, L., Beale, G., Patman, G., Nobili, V., Leathart, J., Grieco, A., Abate, M., Friedman, S. L., Narla, G., Bugianesi, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.004 · Cited by 196
Self-citationConsumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
Sawada, N., Inoue, M., Iwasaki, M., Sasazuki, S., Shimazu, T., Yamaji, T., Takachi, R., Tanaka, Y., Mizokami, M., & Tsugane, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.018 · Cited by 196
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
Sanna, C., Rosso, C., Marietti, M., & Bugianesi, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050717 · Cited by 194
Self-citationSetiawan, V. W., Wilkens, L. R., Lu, S. C., Hernandez, B. Y., Le Marchand, L., & Henderson, B. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.005 · Cited by 189
van der Poorten, D., Samer, C. F., Ramezani-Moghadam, M., Coulter, S., Kacevska, M., Schrijnders, D., Wu, L. E., McLeod, D., Bugianesi, E., Komuta, M., et al. (2013) · Hepatology · doi:10.1002/hep.26072 · Cited by 178
Self-citationDiets and nonalcoholic fatty liver disease: The good and the bad
Asrih, M., & Jornayvaz, F. R. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.11.003 · Cited by 175
Yamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 172
Resolution of Fatty Liver and Risk of Incident Diabetes
Sung, K.-C., Wild, S. H., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1519 · Cited by 169
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Petta, S., Cammà, C., Cabibi, D., Di Marco, V., & Craxì, A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04788.x · Cited by 167
Self-citationSingh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. (2015) · Hepatology · doi:10.1002/hep.27999 · Cited by 163
The Gordian Knot of dysbiosis, obesity and NAFLD
Mehal, W. Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.146 · Cited by 160
Oh, S., Shida, T., Yamagishi, K., Tanaka, K., So, R., Tsujimoto, T., & Shoda, J. (2015) · Hepatology · doi:10.1002/hep.27544 · Cited by 158
Ballestri, S., Nascimbeni, F., Romagnoli, D., & Lonardo, A. (2016) · Hepatology Research · doi:10.1111/hepr.12656 · Cited by 158
Self-citationCardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 155
Filippo, M. D., Moulin, P., Roy, P., Bouma, M. E., Collardeau‐Frachon, S., Chebel-Dumont, S., Peretti, N., Dumortier, J., Zoulim, F., Fontanges, T., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.023 · Cited by 154
Poynard, T., Lassailly, G., Diaz, E., Clément, K., Caiazzo, R. J., Tordjman, J., Munteanu, M., Perazzo, H., Demol, B., Callafe, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030325 · Cited by 153
Käräjämäki, A. J., Pätsi, O.-P., Savolainen, M. J., Kesäniemi, Y. A., Huikuri, H. V., & Ukkola, O. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142937 · Cited by 153
Petäjä, E. M., & Yki‐Järvinen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050633 · Cited by 150
The epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 144
Self-citationNobili, V., Marcellini, M., Marchesini, G., Vanni, E., Manco, M., Villani, A., & Bugianesi, E. (2007) · Diabetes Care · doi:10.2337/dc07-0281 · Cited by 139
Self-citationThe Role of Diet and Nutritional Intervention for the Management of Patients with NAFLD
Francisco Barrera, M., & George, J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.009 · Cited by 139
Yang, Y., Zhang, D., Feng, N., Chen, G., Liu, J., Chen, G., & Zhu, Y. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.005 · Cited by 129
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia
Stadlmayr, A., Aigner, E. S., Steger, B., Scharinger, L., Lederer, D., Mayr, A., Straßer, M., Brunner, E., Heuberger, A., Hohla, F., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02377.x · Cited by 127
Serum Immunoglobulin Levels Predict Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
McPherson, S., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.010 · Cited by 124
Mantovani, A., Rigamonti, A., Bonapace, S., Bolzan, B., Pernigo, M., Morani, G., Franceschini, L., Bergamini, C., Bertolini, L., Valbusa, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0091 · Cited by 124
Self-citationGenetics of nonalcoholic fatty liver disease
Dongiovanni, P., & Valenti, L. V. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.018 · Cited by 120
Self-citationNascimbeni, F., Aron‐Wisnewsky, J., Pais, R., Tordjman, J., Poitou, C., Charlotte, F., Bédossa, P., Poynard, T., Clément, K., Ratziu, V., et al. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2015-000075 · Cited by 120
Self-citationRisk of Cancer in Patients Hospitalized With Fatty Liver
Sørensen, H. T., Mellemkjær, L., Jepsen, P., Thulstrup, A. M., Baron, J. A., Olsen, J. H., & Vilstrup, H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200304000-00015 · Cited by 119
The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.
Lonardo, A., Bellini, M., Tartoni, P., & Tondelli, E. (1997) · PubMed · Cited by 118
Self-citationDasarathy, J., Periyalwar, P., Allampati, S., Bhinder, V., Hawkins, C., Brandt, P., Khiyami, A., McCullough, A. J., & Dasarathy, S. (2013) · Liver International · doi:10.1111/liv.12312 · Cited by 116
Wang, Y., Wang, P., Wang, B., Fu, Z., Zhao, W., & Yan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095485 · Cited by 114
Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population
Hung, C., Tseng, P., Tu, C., Chen, C.-C., Liao, W., Lee, Y., Chiu, H., Lin, H., Ho, Y., Yang, W., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001820 · Cited by 104
Development of hyperinsulinemia and insulin resistance during the early stage of weight gain
Erdmann, J., Kallabis, B., Oppel, U., Sypchenko, O., Wagenpfeil, S., & Schusdziarra, V. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00560.2007 · Cited by 103
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Pichiri, I., Mantovani, A., Zoppini, G., Bonora, E., Barbieri, E., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.005 · Cited by 101
Self-citationHeart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Valbusa, F., Bertolini, L., Zenari, L., Pichiri, I., Dauriz, M., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.04.003 · Cited by 101
Self-citationNuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
Fuchs, C., Traussnigg, S., & Trauner, M. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1571296 · Cited by 100
Alonso, Á., Misialek, J. R., Amiin, M. A., Hoogeveen, R. C., Chen, L. Y., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., & Selvin, E. (2014) · Heart · doi:10.1136/heartjnl-2014-305756 · Cited by 95
Carulli, L., Canedi, I., Rondinella, S., Lombardini, S., Ganazzi, D., Fargion, S. R., Palma, M. D., Lonardo, A., Ricchi, M., Bertolotti, M., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.03.005 · Cited by 93
Self-citationTargher, G., Marchesini, G., & Byrne, C. D. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.002 · Cited by 91
Self-citationPNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
Petta, S., Valenti, L. V. C., Marchesini, G., Marco, V. D., Licata, A., Cammà, C., Barcellona, M. R., Cabibi, D., Donati, B., Fracanzani, A. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074089 · Cited by 88
Self-citationLow birthweight and risk of type 2 diabetes: a Mendelian randomisation study
Wang, T., Huang, T., Li, Y., Zheng, Y., Manson, J. E., Hu, F. B., & Qi, L. (2016) · Diabetologia · doi:10.1007/s00125-016-4019-z · Cited by 87
Liver Fibrosis Progression in Hepatitis C Virus Infection After Seroconversion
Butt, A. A., Yan, P., Re, V. L., Rimland, D., Goetz, M. B., Leaf, D. A., Freiberg, M. S., Klein, M. B., Justice, A. C., & Sherman, K. E. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6502 · Cited by 85
Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
Wild, S. H., Morling, J. R., McAllister, D., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P. J., Sattar, N. A., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.014 · Cited by 84
Bugianesi, E. (2016) · Diabetologia · doi:10.1007/s00125-016-3930-7 · Cited by 83
Self-citationCarulli, L., Ballestri, S., Lonardo, A., Lami, F., Violi, E., Losi, L., Bonilauri, L., Verrone, A. M., Odoardi, M. R., Scaglioni, F., et al. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0609-4 · Cited by 81
Self-citationHuang, K.-H., Leu, H., Wang, Y., Luo, J., Lin, H., Lee, F., Chan, W. L., Lin, J., & Chang, F. Y. (2013) · Colorectal Disease · doi:10.1111/codi.12172 · Cited by 81
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., & Lonardo, A. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0306-9 · Cited by 79
Self-citationFrom NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights.
de Minicis, S., Day, C., & Svegliati-Baroni, G. (2013) · Current pharmaceutical design · doi:10.2174/1381612811319290006 · Cited by 78
Self-citationSingh, D. K., Sakhuja, P., Malhotra, V., Gondal, R., & Sarin, S. K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0074-0 · Cited by 68
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
Lonardo, A., & Loria, P. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07232.x · Cited by 67
Self-citationA “systems medicine” approach to the study of non-alcoholic fatty liver disease
Petta, S., Valenti, L. V. C., Bugianesi, E., Targher, G., Bellentani, S., Bonino, F., Ferrannini, E., Loguercio, C., Lonardo, A., Marra, F., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.027 · Cited by 66
Self-citationLonardo, A., Bellentani, S., Ratziu, V., & Loria, P. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.19 · Cited by 64
Self-citationYou, S. C., Kim, K. J., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, W. J., & Han, K.-H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i4.1158 · Cited by 59
Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis
Giannini, E. G., Marabotto, E., Savarino, V., Trevisani, F., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Farinati, F., Zoli, M., Borzio, F., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.001 · Cited by 57
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Imai, N., Kobayashi, M., Sezaki, H., Matsumoto, N., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00915.x · Cited by 53
The inflammasome in liver disease
Wree, A., & Marra, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.002 · Cited by 52
Self-citationLeikin-Frenkel, A. I., Gonen, A., Shaish, A., Goldiner, I., Leikin-Gobbi, D., Konikoff, F. M., Harats, D., & Gilat, T. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.09.001 · Cited by 49
Cariou, B., Hanf, Lambert-Porcheron, S., & Zair (2013) · Diabetes Care · Cited by 49
A case–control study of non-alcoholic fatty liver disease in breast cancer
Bilici, A. E., Özgüroğlu, M., Mihmanlı, İ., et al. (2007) · Medical Oncology · doi:10.1007/s12032-007-0034-8 · Cited by 45
Reddy, S. K., Hyder, O. N., Marsh, J. W., Sotiropoulos, G. C., Paul, A., Alexandrescu, S. T., Marques, H. P., Pulitanò, C., Barroso, E., Aldrighetti, L. A., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2149-x · Cited by 44
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., & Parola, M. (2014) · PubMed · doi:10.14670/hh-29.33 · Cited by 41
Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease
Kawamura, Y., Arase, Y., Ikeda, K., Akuta, N., Kobayashi, M., Saitoh, S., Suzuki, F., Suzuki, Y., Inao, M., Mochida, S., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.019 · Cited by 40
Benign Hepatocellular Tumors (Adenomatosis) in Nonalcoholic Steatohepatitis: A Case Report
Brunt, E. M., Wolverson, M., & Bisceglie, A. M. D. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871202 · Cited by 38
Liu, T., Vachharajani, N. A., Chapman, W. C., & Brunt, E. M. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.148 · Cited by 37
Bhatt, B. D., Lukose, T., Siegel, A. B., Brown, R. S., & Verna, E. C. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.050 · Cited by 33
Reha, J. L., Lee, S., & Hofmann, L. J. (2014) · The American Surgeon · doi:10.1177/000313481408000624 · Cited by 32
Seko, Y., Sumida, Y., Tanaka, S., Taketani, H., Kanemasa, K., Ishiba, H., Okajima, A., Nishimura, T., Yamaguchi, K., Moriguchi, M., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12407 · Cited by 30
Corey, K. E., Kartoun, U., Zheng, H., Chung, R. T., & Shaw, S. Y. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.44 · Cited by 29
Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood
Valenti, L. V. C., & Romeo, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.010 · Cited by 24
Self-citationNot routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes
Wong, V. W., & Chalasani, N. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.032 · Cited by 23
Valbusa, F., Bonapace, S., Grillo, C., Scala, L., Chiampan, A., Rossi, A., Zoppini, G., Lonardo, A., Arcaro, G., Byrne, C. D., et al. (2016) · Medicine · doi:10.1097/md.0000000000002760 · Cited by 22
Self-citation
Cited by
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001
Self-citationObesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Gart, E., Souto Lima, E., Schuren, F., De Ruiter, C. G. F., Attema, J., Verschuren, L., Keijer, J., Salic, K., Morrison, M. C., & Kleemann, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010001 · Cited by 1,093
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Self-citationBallestri, S., Nascimbeni, F., Baldelli, E., Marrazzo, A., Romagnoli, D., & Lonardo, A. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0556-1 · Cited by 545
Self-citation
Metadata
- Authors
- Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., Miele, L., Morisco, F., Petta, S., Piscaglia, F., Svegliati-Baroni, G., Valenti, L., & Bellentani, S.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 49
- Issue
- 5
- Pages
- 471-483
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W2582145734
- Cited by
- 306
- References
- 203
- FWCI
- 31.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.